Granted
The Board granted a 30 percent evaluation for urticaria from July 7, 2009, as the Veteran's condition required second line treatment.
The deciding factor: The Veteran's urticaria has been treated with topical corticosteroids (triamcinolone acetonide) on a constant basis, which falls under the second line of treatment for chronic urticaria according to the rating criteria.
- Claimed conditions
- urticaria
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 30%
- Decision date
- December 2, 2025
- Citation
- 25014415
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.